Global Drugs for Chronic Obstructive Pulmonary Disorder Market Study 2016-2026, by Segment (Short-Acting Bronchodilators, Corticosteroids, … …), by Market (GOLD 1? FEV1 ? 80%, GOLD 2? 50% ? FEV1 < 80%, … …), by Company (AstraZeneca, Boehringe
SKU ID :99ST-14579485 | Published Date: 05-Oct-2019 | No. of pages: 56Description
Summary
The global Drugs for Chronic Obstructive Pulmonary Disorder market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Demand Coverage (Market Size & Forecast, Consumer Distribution):
GOLD 1? FEV1 ? 80%
GOLD 2? 50% ? FEV1 < 80%
GOLD 3? 30% ? FEV1 < 50%
GOLD 4? FEV1 < 30%
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
0
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Drugs for Chronic Obstructive Pulmonary Disorder market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Demand Coverage (Market Size & Forecast, Consumer Distribution):
GOLD 1? FEV1 ? 80%
GOLD 2? 50% ? FEV1 < 80%
GOLD 3? 30% ? FEV1 < 50%
GOLD 4? FEV1 < 30%
Company Coverage (Sales data, Main Products & Services etc.):
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
0
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now